XTL Biopharmaceuticals Ltd ADR (XTLB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.76
• Market Cap: $7.55M
• EPS: $-0.90
• 52-Week High: $2.57
• 52-Week Low: $0.53

Market Sentiment

XTL Biopharmaceuticals Ltd ADR currently has a Bearish sentiment score of -0.29.

About XTL Biopharmaceuticals Ltd ADR

XTL Biopharmaceuticals Ltd. is an innovative biopharmaceutical company headquartered in Ramat Gan, Israel, focusing on developing and commercializing novel therapeutic solutions for autoimmune diseases. With a robust pipeline and proprietary technologies, XTL is committed to addressing significant unmet medical needs and improving patient outcomes. The company's strategic focus on emerging healthcare opportunities positions it favorably within the dynamic biopharma sector, making it a compell...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for XTL Biopharmaceuticals Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XTLB pay dividends?

XTL Biopharmaceuticals Ltd ADR (XTLB) does not currently pay a regular dividend.

What is XTLB's market cap?

XTL Biopharmaceuticals Ltd ADR (XTLB) has a market capitalization of $7.55M with a current stock price of $0.76.